{"@id":"https://bioecon.ru/technology/ai-based-ada-immunogenicity-prediction/","@type":"Technology","cluster":"bioinformatics-omics","formats":{"html":"https://en.bioecon.ru/technology/ai-based-ada-immunogenicity-prediction/","json":"https://en.bioecon.ru/api/v1/technology/ai-based-ada-immunogenicity-prediction/index.json"},"id":"ai-based-ada-immunogenicity-prediction","industries":["diagnostics","medtech-devices","pharma"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/diagnostics/","https://bioecon.ru/industries/medtech-devices/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/chitose/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/hlb-genex/","https://bioecon.ru/companies/ecowin/","https://bioecon.ru/companies/vland-biotech/","https://bioecon.ru/companies/grupo-hidrogood/"]},"maturity":7,"name":"AI-Based Anti-Drug Antibody (ADA) Immunogenicity Prediction","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"3D biotherapeutic epitope mapping"},{"n":2,"title":"HLA Class-II pan-allelic binding prediction"},{"n":3,"title":"Human tonsil organoid ex-vivo challenge"},{"n":4,"title":"De-immunization candidate engineering"}],"summary":"In-silico structural machine learning architectures predicting anti-drug antibody (ADA) titers, HLA-class II epitope presentation, and CD4+ T-cell activation potential of therapeutic biologics, experimentally validated using human ex vivo tonsil organoid cultures.","url":"/technology/ai-based-ada-immunogenicity-prediction/","verified":"2026-11-22"}